3382 Results

People

  1. Hudis
    Hudis
  2. Soslow
    Soslow
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Motzer
    Motzer
  6. Rusch
    Rusch
  7. Patil
    Patil
  8. Barakat
    Barakat
  9. Kris
    Kris
  10. Scher
    Scher

Groups

  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)
  7. Department of Pathology and Laboratory Medicine (408)
  8. Center for Hematologic Malignancies (395)
  9. Epidemiology and Biostatistics (369)
  10. Hematologic Malignancies, Division of (342)
  1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and validation of a prediction tool for hand-foot skin reaction (HFSR) in patients receiving sorafenib
    Meeting Abstract

    Yu, J.; Dranitsaris, G.; Vincent, M. D.; Huang, L.; Fang, F.; Lacouture, M. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Can we really treat patients older than age 70 with a chemotherapy doublet for non-small cell lung cancer (NSCLC)?
    Meeting Abstract

    Zauderer, M. G.; Sima, C. S.; Korc-Grodzicki, B.; Kris, M. G.; Krug, L. M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Metrics for measuring tumor burden: A comparison of unidimensional and volumetric measurements
    Meeting Abstract

    Zhao, B.; Ghiorghiu, D. C.; Lefkowitz, R. A.; Marley, S. E.; Tan, Y.; Scott, M. L.; Mann, H.; Schwartz, L. H.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC)
    Meeting Abstract

    Kris, M. G.; Johnson, B. E.; Kwiatkowski, D. J.; Iafrate, A. J.; Wistuba, I. I.; Aronson, S. L.; Engelman, J. A.; Shyr, Y.; Khuri, F. R.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical features of germ cell tumors (GCT) in men age 50 or older: Successful outcome and tolerability to chemotherapy for advanced disease
    Meeting Abstract

    Voss, M. H.; Jacobsen, E. P.; Patil, S.; Turkula, S.; Jia, X.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.; Feldman, D. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Tumor microenvironment derived biomarkers for the early detection of pancreatic cancer (PDAC)
    Meeting Abstract

    Wehr, A. Y.; Blair, I. A.; Yu, K. H.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I study of vorinostat in combination with temozolomide in patients with malignant gliomas
    Meeting Abstract

    Wen, P. Y.; Puduvalli, V. K.; Kuhn, J. G.; Reid, J. M.; Lamborn, K.; Cloughesy, T. F.; Chang, S. M.; Drappatz, J.; Yung, W. K. A.; Gilbert, M. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Global, multicenter, open-label, randomized phase II trial comparing gemcitabine (G) with G plus AGS-1C4D4 (A) in patients (pts) with metastatic pancreatic cancer (mPC)
    Meeting Abstract

    Wolpin, B. M.; O'Reilly, E. M.; Ko, Y.; Blaszkowsky, L. S.; Rarick, M. U.; Rocha Lima, C. M. S.; Ritch, P. S.; Chan, E.; Spratlin, J. L.; Macarulla, T.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Timing in adjuvant chemotherapy (CTX) initiation among women with breast cancer (BC) at National Comprehensive Cancer Network (NCCN) centers: An analysis from the NCCN Outcomes Database
    Meeting Abstract

    Vandergrift, J. L.; Niland, J. C.; Theriault, R. L.; Edge, S. B.; Wong, Y.; Loftus, L. S.; Breslin, T. M.; Hudis, C.; Javid, S. H.; Rugo, H. S.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma
    Meeting Abstract

    Winter, J. M.; Tang, L. H.; Klimstra, D. S.; Brennan, M. F.; O'Reilly, E. M.; Jarnagin, W. R.; Allen, P. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save